Literature DB >> 21159389

Sphingosine-1-phosphate and immune regulation: trafficking and beyond.

Hongbo Chi1.   

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lipid with important functions in the immune system. S1P levels are regulated by the balance between its synthesis through sphingosine kinases and its degradation by S1P lyase. S1P signals through plasma membrane G-protein-coupled receptors (S1PR1-S1PR5) or acts directly on intracellular targets. Although it has long been known that the S1P-S1PR1 axis mediates T cell egress from lymphoid organs, recent studies have revealed intrinsic functions of S1P and its receptors in both innate and adaptive immune systems that are independent of immune cell trafficking. Here I summarize recent advances in understanding of the roles of S1P and S1P receptors in inflammatory and allergic responses and lymphocyte differentiation, which directly contribute to the regulation of inflammatory and autoimmune diseases. I also describe strategies to target S1P and S1P receptors for immune-mediated diseases, particularly the immunosuppressant FTY720 (fingolimod), which has recently become the first oral therapy for relapsing multiple sclerosis. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159389      PMCID: PMC3017656          DOI: 10.1016/j.tips.2010.11.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  81 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

2.  The immune modulator FTY720 targets sphingosine 1-phosphate receptors.

Authors:  Volker Brinkmann; Michael D Davis; Christopher E Heise; Rainer Albert; Sylvain Cottens; Robert Hof; Christian Bruns; Eva Prieschl; Thomas Baumruker; Peter Hiestand; Carolyn A Foster; Markus Zollinger; Kevin R Lynch
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

3.  KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Authors:  Hisashi Shimizu; Masafumi Takahashi; Takashi Kaneko; Takashi Murakami; Yoji Hakamata; Shinji Kudou; Tetsuya Kishi; Kazunori Fukuchi; Satoru Iwanami; Kazuhiko Kuriyama; Tokutaro Yasue; Shin Enosawa; Koshi Matsumoto; Izumi Takeyoshi; Yasuo Morishita; Eiji Kobayashi
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

4.  Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1.

Authors:  Hongbo Chi; Richard A Flavell
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.

Authors:  Tsukasa Ohmori; Yutaka Yatomi; Makoto Osada; Fuminori Kazama; Toshiro Takafuta; Hitoshi Ikeda; Yukio Ozaki
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

6.  Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes.

Authors:  Markus H Gräler; Mei-Chuan Huang; Susan Watson; Edward J Goetzl
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

7.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.

Authors:  Mehrdad Matloubian; Charles G Lo; Guy Cinamon; Matthew J Lesneski; Ying Xu; Volker Brinkmann; Maria L Allende; Richard L Proia; Jason G Cyster
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

8.  Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration.

Authors:  Maria L Allende; Jennifer L Dreier; Suzanne Mandala; Richard L Proia
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

9.  Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.

Authors:  M Germana Sanna; Jiayu Liao; Euijung Jo; Christopher Alfonso; Min-Young Ahn; Melissa S Peterson; Bill Webb; Sophie Lefebvre; Jerold Chun; Nathanael Gray; Hugh Rosen
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

10.  Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo.

Authors:  Peter N Pushparaj; Jayapal Manikandan; Hwee Kee Tay; Shiau Chen H'ng; Srinivasan D Kumar; Josef Pfeilschifter; Andrea Huwiler; Alirio J Melendez
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

View more
  80 in total

1.  Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.

Authors:  Takashi Yoshino; Hiroko Tabunoki; Shigeo Sugiyama; Keitaro Ishii; Seung U Kim; Jun-Ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.046

2.  The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice.

Authors:  Shigetomo Fukuhara; Szandor Simmons; Shunsuke Kawamura; Asuka Inoue; Yasuko Orba; Takeshi Tokudome; Yuji Sunden; Yuji Arai; Kazumasa Moriwaki; Junji Ishida; Akiyoshi Uemura; Hiroshi Kiyonari; Takaya Abe; Akiyoshi Fukamizu; Masanori Hirashima; Hirofumi Sawa; Junken Aoki; Masaru Ishii; Naoki Mochizuki
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 3.  Influenza lung injury: mechanisms and therapeutic opportunities.

Authors:  David J Gregory; Lester Kobzik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

4.  A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.

Authors:  Alessandro Didonna; Noriko Isobe; Stacy J Caillier; Kathy H Li; Alma L Burlingame; Stephen L Hauser; Sergio E Baranzini; Nikolaos A Patsopoulos; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

Review 5.  Sphingosine-1-phosphate signaling and its role in disease.

Authors:  Michael Maceyka; Kuzhuvelil B Harikumar; Sheldon Milstien; Sarah Spiegel
Journal:  Trends Cell Biol       Date:  2011-10-14       Impact factor: 20.808

6.  Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer.

Authors:  Sunil Acharya; Jun Yao; Ping Li; Chenyu Zhang; Frank J Lowery; Qingling Zhang; Hua Guo; Jingkun Qu; Fei Yang; Ignacio I Wistuba; Helen Piwnica-Worms; Aysegul A Sahin; Dihua Yu
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 7.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

Review 8.  Systemic lupus erythematosus: a therapeutic challenge for the XXI century.

Authors:  Manuel F Ugarte-Gil; Graciela S Alarcón
Journal:  Clin Rheumatol       Date:  2014-02-28       Impact factor: 2.980

Review 9.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

10.  Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages.

Authors:  Philipp Burow; Manuela Klapperstück; Fritz Markwardt
Journal:  Pflugers Arch       Date:  2014-06-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.